Tristel Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00B07RVT99
GBP
3.68
0.03 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Tristel Plc stock-summary
stock-summary
Tristel Plc
Pharmaceuticals & Biotechnology
Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company's technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals. The segments products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The segments products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The segments products are marketed under the brand, Crystel. Its manufacturing facility is located in Newmarket, Cambridgeshire.
Company Coordinates stock-summary
Company Details
Lynx Business Park,Fordham Road , SNAILWELL None : CB8 7NY
stock-summary
Tel: 44 1638 72150044 1638 721500
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Bruno Holthof
Non-Executive Chairman of the Board
Paul Swinney
Chief Executive, Executive Director
Elizabeth Dixon
Group Finance Director, Executive Director
Mr. Paul Barnes
Non-Executive Director
Bruce Green
Non-Executive Director
Mr. Tom Jenkins
Non-Executive Director
Ms. Isabel Napper
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 175 Million (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

382.87%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

23.44%

stock-summary
Price to Book

5.32